The mRNA and protein levels of METTL16 were reduced by 2-fold (Fig. 1e, S5, and S11), contributing to decreased protein translation (Fig. 4b), lower methylation potential (Fig. 5d), and poor cell migration (Fig. 6) in MDS cells. Here, METTL16 is linked to myelodysplastic syndrome.